| 
			1 | 
		
			
									
						Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma Enthalten in Liver cancer Bd. 11, 2022, Nr. 5: 460-473. 14 S.
					
							 | 
									
			
								
									  
								
			 | 
		
		
			
			 
			
					    					 
							
			 | 
			2 | 
		
			
									
						First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial Enthalten in Nature medicine Bd. 29, 10.8.2023, Nr. 8, date:8.2023: 2087-2098
					
							 | 
									
			
								
									  
								
			 | 
		
		
			
			 
			
					    					 
							
			 | 
			3 | 
		
			
									
						Homologous recombination deficiency (HRD) tests for ovarian cancer: a multicenter French phase II study (HERO) Enthalten in BMC cancer Bd. 25, 1.7.2025, Nr. 1, date:12.2025: 1-9
					
							 | 
									
			
								
									  
								
			 | 
		
		
			
			 
			
					    					 
							
			 | 
			4 | 
		
			
									
						Management of patients with posterior urethral valves “from the fetus to adolescence”: French national diagnostic and care protocol (NDCP) Enthalten in Orphanet journal of rare diseases Bd. 20, 12.5.2025, Nr. 1, date:12.2025: 1-24
					
							 | 
									
			
								
									  
								
			 |